We report a case of two siblings with progressive myoclonus epilepsy whose parents were not consanguineous. Their clinical symptoms were typical of Lafora disease (LD), but skin biopsies revealed no Lafora bodies. Whole-exome sequencing identified a recurrent homozygous frameshift variant in the NHLRC1 gene in both siblings. The genetic analysis was useful for the diagnosis of LD, as neither consanguinity nor Lafora bodies were found.
Lafora disease (LD, OMIM # 254780) is one of progressive myoclonus epilepsy (PME) with a mode of autosomal recessive inheritance. The symptoms usually start in the teenage years, and development is normal before the onset of seizures. The electroencephalogram (EEG) shows occipital spike-and-slow waves in the early stage of the disease. The occipital seizures with visual onset symptoms and myoclonus are easily induced by intermittent photic stimulation. Mental dysfunction and ataxic movement progress rapidly in a year 1 . EPM2A and NHLRC1 (EPM2B, RefSeq accession number NM_198586.2) are well-known causative genes for LD. More than 80% of LD patients carry variants in either gene; however, there is a possibility that another candidate gene may be involved in LD pathogenesis because some LD patients lack variants in either of them 2,3 . In the Japanese population, variants in NHLRC1 are the most frequent cause of LD 4 . Here, we report two Japanese siblings with LD carrying a homozygous variant in the NHLRC1 gene.
The proband ( Fig. 1a ; III-4) was born as the second child of unrelated Japanese parents. Her father was born in a town of northern Kyusyu and was healthy. Her mother was born in another town of northern Kyusyu and had a history of thyroid cancer. The patient had been a smart student until she suffered a generalized tonic clonic convulsion (GTC) at the age of 12 years. The initial symptom preceding GTC was visual hallucination. EEG showed occipital sporadic spikes and continuous slow waves in the bilateral occipital regions ( Fig. 2a ). She sometimes suffered visual hallucinations as a seizure manifestation and developed eyelid myoclonus. Six months after her first seizure, she experienced a second GTC and was diagnosed as having idiopathic occipital epilepsy with secondary generalization. She was prescribed carbamazepine but began to experience weekly GTCs and eyelid and generalized myoclonic seizures. Her cognitive and motor functions declined rapidly.
The proband was referred to our hospital at the age of 14 years. Myoclonic movement was occasionally observed in her fingers and eyelids. An examination of peripheral blood cells (PBCs) and sera showed insignificantly elevated hepatic enzyme levels. Urine and cerebrospinal fluid test results were normal. EEGs showed slow background activity, frequent generalized slow waves, and generalized and focal spikes ( Fig. 2b ). Bilateral diffuse slow waves intermingled with spikes were easily induced by intermittent photic stimulation ( Fig. 2c ). Fundoscopy revealed no abnormality. A somatosensory evoked potential (SEP) analysis showed a giant SEP. A brain magnetic resonance imaging scan showed moderate cerebral and cerebellar atrophy (Fig. 2d ). These electroclinical findings suggested LD, but Lafora bodies were not found by palm skin or rectal mucosal biopsy. We sent genomic DNA isolated from her PBCs to a company for analyses of the EPM2A and NHLRC1 genes. Upon analysis, the company reported no variants in either EPM2A or NHLRC1. Furthermore, we excluded the following diseases: Gaucher disease by a glucocerebrosidase enzyme assay in fibroblasts and the absence of Gaucher cells in the bone marrow; Unverricht-Lundborg disease and Dentato-rubro-pallido-luysian atrophy by genetic examinations; and mitochondrial disease by the lactate and pyruvate levels in the serum and cerebrospinal fluid.
At the age of 16 years, the proband became bedridden. She continuously had focal and generalized myoclonus and seizures despite combination therapy with sodium valproate, clonazepam, lamotrigine, and topiramate. Brain MRI showed progression of cerebellar atrophy when she was 17 years old ( Fig. 2e) .
The younger sister of the proband (Fig. 1a ; III-5) experienced a similar GTC following visual hallucinations and myoclonus since the age of 11 years. She was also of normal intelligence before disease onset, and memory disturbance and ataxia appeared a few years after onset. The subsequent onset in this younger sister strongly suggested that the two sisters suffered from an inherited PME.
When the proband was 17 years old and her younger sister was 15 years old, we performed whole-exome sequencing. The results showed that both patients had a homozygous frameshift variant in the NHLRC1 gene ( Fig. 1b Considering the clinical symptoms and the results of genetic examinations, we diagnosed both patients with LD due to a homozygous frameshift variant in the NHLRC1 gene.
The siblings exhibited the typical clinical characteristics of LD. Their PME with occipital seizures and photosensitivity appeared during their teenage years. Their intellectual and motor functions declined rapidly from the onset. Lafora bodies, a characteristic feature of LD showing deposition of abnormal glycogen in the cytoplasm, were not found in our cases, and definitive diagnosis was performed by detection of the NHLRC1 variant. The prevalence of EPM2A or NHLRC1 variants in classical LD patients was much higher (93%) than the detection rate of Lafora bodies (67%) 6 . Therefore, mutation screening of the EPM2A and NHLRC1 genes 
